MiniMed Group, Inc.(MMED)
$16.01-0.25 (-1.54%)
MMED
MiniMed Group, Inc. financials statements
$16.01
At close:-0.25 (-1.54%)
Want to see MMED full AI Analyst Report?
MiniMed Group, Inc. (MMED) Ratios
72 Followers
MiniMed Group, Inc. Ratios
MMED's free cash flow for Q1 2026 was $-90.00M. For the 2026 fiscal year, MMED's free cash flow was decreased by $-41.00M and operating cash flow was $-49.00M. See a summary of the company’s cash flow.
| Ratios | Apr 26 | Apr 25 | Apr 24 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 1.92 | 1.32 | 1.73 |
| Quick Ratio | 1.43 | 0.89 | 1.16 |
| Cash Ratio | 0.42 | 0.02 | 0.10 |
| Solvency Ratio | -0.17 | -0.12 | 0.03 |
| Operating Cash Flow Ratio | -0.28 | 0.20 | 0.08 |
| Short-Term Operating Cash Flow Coverage | -1.44 | 0.00 | 0.00 |
| Net Current Asset Value | $ 329.00M | $ 69.00M | $ 249.00M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.03 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.04 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.28 | 1.26 | 1.19 |
| Debt Service Coverage Ratio | 0.56 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.57 | 0.04 | 0.03 |
| Net Debt to EBITDA | -0.75 | 0.00 | -0.77 |
| Profitability Margins | |||
| Gross Profit Margin | 54.16% | 56.17% | 58.16% |
| EBIT Margin | 1.58% | -1.33% | -2.79% |
| EBITDA Margin | 6.61% | 3.94% | 2.43% |
| Operating Profit Margin | 1.58% | -7.44% | -2.79% |
| Pretax Profit Margin | -6.03% | -7.48% | -2.84% |
| Net Profit Margin | -10.67% | -9.21% | -4.54% |
| Continuous Operations Profit Margin | -10.15% | -9.24% | -4.37% |
| Net Income Per EBT | 177.01% | 123.15% | 160.00% |
| EBT Per EBIT | -381.63% | 100.50% | 101.45% |
| Return on Assets (ROA) | -7.15% | -5.95% | -2.74% |
| Return on Equity (ROE) | -9.17% | -7.51% | -3.25% |
| Return on Capital Employed (ROCE) | 1.25% | -5.79% | -1.93% |
| Return on Invested Capital (ROIC) | 1.20% | -5.77% | -1.93% |
| Return on Tangible Assets | -14.59% | -13.77% | -6.67% |
| Earnings Yield | -9.77% | -4.81% | -2.09% |
| Efficiency Ratios | |||
| Receivables Turnover | 4.74 | 4.76 | 4.87 |
| Payables Turnover | 8.72 | 5.80 | 5.43 |
| Inventory Turnover | 4.17 | 3.84 | 3.53 |
| Fixed Asset Turnover | 4.36 | 3.85 | 3.88 |
| Asset Turnover | 0.67 | 0.65 | 0.60 |
| Working Capital Turnover Ratio | 7.09 | 8.96 | 0.00 |
| Cash Conversion Cycle | 122.76 | 108.84 | 111.03 |
| Days of Sales Outstanding | 77.07 | 76.63 | 74.95 |
| Days of Inventory Outstanding | 87.53 | 95.08 | 103.28 |
| Days of Payables Outstanding | 41.84 | 62.88 | 67.20 |
| Operating Cycle | 164.60 | 171.71 | 178.23 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | -0.77 | 0.50 | 0.15 |
| Free Cash Flow Per Share | -1.64 | -0.19 | -0.38 |
| Dividend Paid and CapEx Coverage Ratio | -0.88 | 0.73 | 0.28 |
| Capital Expenditure Coverage Ratio | -0.88 | 0.73 | 0.28 |
| Operating Cash Flow Coverage Ratio | -1.36 | 12.73 | 5.13 |
| Operating Cash Flow to Sales Ratio | -0.06 | 0.05 | 0.02 |
| Free Cash Flow Yield | -12.40% | -1.02% | -2.00% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -10.23 | -20.78 | -47.78 |
| Price-to-Sales (P/S) Ratio | 1.09 | 1.91 | 2.17 |
| Price-to-Book (P/B) Ratio | 0.94 | 1.56 | 1.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.06 | -97.97 | -50.01 |
| Price-to-Operating Cash Flow Ratio | -17.19 | 37.09 | 130.51 |
| Price-to-Earnings Growth (PEG) Ratio | -0.23 | -0.17 | -2.71 |
| Enterprise Value Multiple | 15.78 | 48.53 | 88.41 |
| Enterprise Value | 3.23B | 5.19B | 5.30B |
| EV to EBITDA | 15.78 | 48.53 | 88.41 |
| EV to Sales | 1.04 | 1.91 | 2.15 |
| EV to Free Cash Flow | -7.70 | -97.97 | -49.58 |
| EV to Operating Cash Flow | -16.42 | 37.09 | 129.39 |
| Tangible Book Value Per Share | 4.87 | 3.37 | 3.68 |
| Shareholders’ Equity Per Share | 14.07 | 11.86 | 12.28 |
| Tax and Other Ratios | |||
| Effective Tax Rate | -0.68 | -0.24 | -0.54 |
| Revenue Per Share | 12.09 | 9.67 | 8.79 |
| Net Income Per Share | -1.29 | -0.89 | -0.40 |
| Tax Burden | 1.77 | 1.23 | 1.60 |
| Interest Burden | -3.82 | 5.64 | 1.01 |
| Research & Development to Revenue | 0.14 | 0.16 | 0.18 |
| SG&A to Revenue | 0.38 | 0.42 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 |
| Income Quality | 0.62 | -0.71 | -0.38 |
Currency in USD

